Evangelista Dominga

Dominga Evangelista is a licensed chemist with a PhD in biotechnology, biocomputational, pharmaceutical and pharmacological sciences from the University of Bologna (2022–2024). Her PhD project focused on applying a Deep Learning (DL) algorithm to predict the Persistence, Bioaccumulation and Toxicity (PBT) of pharmaceuticals and Drug-Induced Liver Injury (DILI). She carried out a research period as a visiting PhD student at OMass Therapeutics (Oxford, UK) and, since October 2025, has been a Research Fellow at ISOF-CNR, where she studies the stability of anticancer molecules in liposomal nanocarriers.

Liposomal nanocarriers • Chemical stability • Anticancer molecules • Formulation

Formulation and characterisation of liposomes and nanocarriers for bioactive molecules, HPLC-MS, NMR spectroscopy, GC, DLS, data analysis using Python, and the use of deep learning tools for predicting molecular properties.